Medication | Clinical use | Endocrine dysfunction | Mechanism of action |
Glucocorticoids | Antiinflammatory therapy | Exogenous Cushing's syndrome; glucocorticoid deficiency upon discontinuation; hypogonadism | Suppresses hypothalamic-pituitary-adrenal (HPA) axis and hypothalamic-pituitary-gonadal (HPG) axes |
HIV protease inhibitors | Antiretroviral therapy (ART) | Hyperprolactinemia | May stimulate lactotrophs directly or inhibit metabolism of other medications |
Ketoconazole | Antifungal therapy | Adrenal insufficiency; hypogonadism | Impairs steroid hormone synthesis |
Megestrol acetate | Appetite stimulant | Cushing's syndrome (rarely); hyperglycemia; hypogonadism; glucocorticoid deficiency upon discontinuation | Intrinsic glucocorticoid-like and progestational activity |
Opiates | Analgesic | Impaired cortisol response to ACTH stimulation; hypogonadism | Alterations in HPA and HPG axes |
Ritonavir, Cobicistat | ART pharmacologic booster | Exogenous Cushing's syndrome (with concomitant use of synthetic glucorticoids) | Effects on hepatic cytochromes and drug metabolism |
Rifampin | Antimycobacterial therapy | Adrenal insufficiency | Increases metabolic clearance of hormones |
Sulfonamides | Antibiotic therapy | Hyporeninemic hypoaldosteronism | Interstitial nephritis |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟